FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrew Blann

Research Profile

Chemicals & Drugs

Anatomy

Concepts & Ideas

Physiology

Platelet Activation

Procedures

Disorders

Co-author Network

Publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrew Blann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Eduard Shantsila; Alena Shantsila; Andrew D Blann; Gregory Y H Lip
Left ventricular fibrosis in atrial fibrillation.
The American journal of cardiology 2013;111(7):996-1001.
2013: Andrew D Blann
A procoagulant state and endothelial dysfunction in obese children.
British journal of haematology 2013;160(5):717-8.
2013: Andrew D Blann; Gregory Y H Lip
Atrial fibrillation and thrombosis: the missing molecular links.
Journal of the American College of Cardiology 2013;61(8):861-2.
2013: Andrew D Blann; Nadya Kuzniatsova; Gregory Y H Lip
Vascular and platelet responses to aspirin in patients with coronary artery disease.
European journal of clinical investigation 2013;43(1):91-9.
2012: Eduard Shantsila; Benjamin J Wrigley; Andrew D Blann; Paramjit S Gill; Gregory Y H Lip
A contemporary view on endothelial function in heart failure.
European journal of heart failure 2012;14(8):873-81.
2012: Will Foster; Gregory Y H Lip; Karim Raza; David Carruthers; Andrew D Blann
An observational study of endothelial function in early arthritis.
European journal of clinical investigation 2012;42(5):510-6.
2012: Andrew D Blann
Endothelial cell activation markers in cancer.
Thrombosis research 2012;129 Suppl 1():S122-6.
2012: Vellore J Karthikeyan; Deirdre A Lane; Gregory Y H Lip; Sabah Baghdadi; D Gareth Beevers; Andrew D Blann
Angiogenin and hemoxygenase in pregnancy: influence of hypertension.
Angiology 2012;63(3):194-8.
2012: Sukhjinder Marwah; A Walls; Andrew D Blann
Relationship between vitamin D and red blood cell indices in South Asians and White Europeans.
British journal of biomedical science 2012;69(4):182-5.
2012: Vellore J Karthikeyan; Deirdre A Lane; Gregory Y H Lip; Sabah Baghdadi; D Gareth Beevers; Andrew D Blann
Soluble Fas and Fas ligand in pregnancy: influence of hypertension.
Angiology 2012;63(1):35-8.
2011: Jolanta Siller-Matula; Andrew D Blann; Christine Mannhalter; Michael Schwameis; Bernd Jilma
Thrombin as a multi-functional enzyme. Focus on in vitro and in vivo effects.
Thrombosis and haemostasis 2011;106(6):1020-33.
2011: D Kaireviciute; Gintaras Kalinauskas; G Y H Lip; M Maheshwari; Gediminas Norkunas; H Sihota; Vytautas Sirvydis; Giedrius Uzdavinys; U Zanetto; A Aidietis; B Balakrishnan; Andrew D Blann
Intracardiac expression of markers of endothelial damage/dysfunction, inflammation, thrombosis, and tissue remodeling, and the development of postoperative atrial fibrillation.
Journal of thrombosis and haemostasis : JTH 2011;9(12):2345-52.
2011: Eduard Shantsila; Luke D Tapp; Benjamin Wrigley; Andrew D Blann; Paramjit S Gill; Alena Shantsila; Gregory Y H Lip
Ethnic differences in macrovascular and microvascular function in systolic heart failure.
Circulation. Heart failure 2011;4(6):754-62.
2011: Rumi J Jaumdally; Gregory Y H Lip; Chetan Varma; Andrew D Blann
Impact of high-dose atorvastatin on endothelial, platelet, and angiogenic indices: effect of ethnicity, cardiovascular disease, and diabetes.
Angiology 2011;62(7):571-8.
2011: Rebekka Heitmar; Gregory Y H Lip; Robert P Cubbidge; Doina Gherghel; Andrew D Blann
Altered blood vessel responses in the eye and finger in coronary artery disease.
Investigative ophthalmology & visual science 2011;52(9):6199-205.
2011: Andrew D Blann; Balu Balakrishnan; Eduard Shantsila; Peter Ryan; Gregory Y H Lip
Endothelial progenitor cells and circulating endothelial cells in early prostate cancer: a comparison with plasma vascular markers.
The Prostate 2011;71(10):1047-53.
2011: Khedar S Ramcharan; Gregory Y H Lip; Paul S Stonelake; Andrew D Blann
The endotheliome: a new concept in vascular biology.
Thrombosis research 2011;128(1):1-7.
2011: Andrew D Blann; B Balakrishnan; Peter Ryan; G Y H Lip
Increased levels of plasma haemoxygenase-1 in prostate cancer.
Prostate cancer and prostatic diseases 2011;14(2):114-7.
2011: V J Karthikeyan; Andrew D Blann; Sabah Baghdadi; Deirdre A Lane; D Gareth Beevers; Gregory Y H Lip
Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor.
Clinical research in cardiology : official journal of the German Cardiac Society 2011;100(6):531-7.
2011: Andrew D Blann; Zoe Draper
Platelet activation as a marker of heart attack.
Clinica chimica acta; international journal of clinical chemistry 2011;412(11-12):841-2.
2011: Junette S Mohan; Gregory Y H Lip; Andrew D Blann; David Bareford; Janice M Marshall
Endothelium-dependent and endothelium-independent vasodilatation of the cutaneous circulation in sickle cell disease.
European journal of clinical investigation 2011;41(5):546-51.
2011: T Evans; O Sany; P Pearmain; Raji Ganesan; Andrew D Blann; S Sundar
Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006.
British journal of cancer 2011;104(9):1505-10.
2011: P C Bennett; P S Gill; S Silverman; Andrew D Blann; J Chackathayil; G Y H Lip
Hemostatic cardiovascular risk factors, common carotid-intima medial thickness and peripheral arterial disease in South Asians and African Caribbeans: a substudy to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study.
Journal of thrombosis and haemostasis : JTH 2011;9(4):645-52.
2011: P C Bennett; P S Gill; S Silverman; Andrew D Blann; G Y H Lip
Ethnic differences in common carotid intima-media thickness, and the relationship to cardiovascular risk factors and peripheral arterial disease: the Ethnic-Echocardiographic Heart of England Screening Study.
QJM : monthly journal of the Association of Physicians 2011;104(3):245-54.
2011: Philip C Bennett; Andrew D Blann; Gregory Yh Lip; Stanley Silverman; Paramjit S Gill
Validation of the Edinburgh Claudication Questionnaire in 1st generation Black African-Caribbean and South Asian UK migrants: a sub-study to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study.
BMC medical research methodology 2011;11():85.
2011: Andrew D Blann; Simon Dunmore
Arterial and venous thrombosis in cancer patients.
Cardiology research and practice 2011;2011():394740.
2010: Rebekka Heitmar; Andrew D Blann; Robert P Cubbidge; Gregory Y H Lip; Doina Gherghel
Continuous retinal vessel diameter measurements: the future in retinal vessel assessment?
Investigative ophthalmology & visual science 2010;51(11):5833-9.
2010: P C Bennett; G Y H Lip; S Silverman; Andrew D Blann; P S Gill
The contribution of cardiovascular risk factors to peripheral arterial disease in South Asians and Blacks: a sub-study to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study.
QJM : monthly journal of the Association of Physicians 2010;103(9):661-9.
2010: Will Foster; David Carruthers; Gregory Y H Lip; Andrew D Blann
Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment.
Journal of thrombosis and thrombolysis 2010;29(4):437-42.
2010: Will Foster; David Carruthers; Gregory Y H Lip; Andrew D Blann
Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment.
The Journal of rheumatology 2010;37(4):711-6.
2009: Norman R Williams; Andrew D Blann
Red wine: can you have too much of a good thing?
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2009;16(5):638.
2009: Patrick K Y Goon; Gregory Y H Lip; Paul S Stonelake; Andrew D Blann
Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index.
Neoplasia (New York, N.Y.) 2009;11(8):771-9.
2009: Ali Hamaad; Michael D Sosin; Andrew D Blann; Gregory Y H Lip; Robert J MacFadyen
Markers of thrombosis and hemostasis in acute coronary syndromes: relationship to increased heart rate and reduced heart-rate variability.
Clinical cardiology 2009;32(4):204-9.
2009: Will Foster; Eduard Shantsila; David M Carruthers; Gregory Y H Lip; Andrew D Blann
Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage/dysfunction.
Rheumatology (Oxford, England) 2009;48(3):285-8.
2009: AS Arunkalaivanan; A Morrison; S Jha; Andrew D Blann
Prevalence of urinary and faecal incontinence among female members of the Hypermobility Syndrome Association (HMSA).
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 2009;29(2):126-8.
2009: Will Foster; David Carruthers; Gregory Y H Lip; Andrew D Blann
Relationships between endothelial, inflammatory and angiogenesis markers in rheumatoid arthritis: implications for cardiovascular pathophysiology.
Thrombosis research 2009;123(4):659-64.
2009: Andrew D Blann; Chee W Khoo
The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.
Vascular health and risk management 2009;5():693-704.
2009: Andrew D Blann; B R Nation
Good analytical practice: statistics and handling data in biomedical science: A primer and directions for authors. Part 2: analysis of data from three or more groups, and instructions for authors.
British journal of biomedical science 2009;66(1):42-6.
2008: Christopher J Boos; B Balakrishnan; Andrew D Blann; G Y H Lip
The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis.
Journal of thrombosis and haemostasis : JTH 2008;6(11):1841-50.
2008: Naglaa Idriss; Andrew D Blann; Gregory Y H Lip
Hemoxygenase-1 in cardiovascular disease.
Journal of the American College of Cardiology 2008;52(12):971-8.
2008: Gregory Y H Lip; Andrew D Blann
Endothelium and fibrinolysis in hypertension: important facets of a prothrombotic state?
Hypertension 2008;52(2):218-9.
2008: Eduard Shantsila; Andrew D Blann; G Y H Lip
Circulating endothelial cells: from bench to clinical practice.
Journal of thrombosis and haemostasis : JTH 2008;6(5):865-8.
2008: Andrew D Blann; Junette S Mohan; David Bareford; G Y H Lip
Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype.
Journal of thrombosis and thrombolysis 2008;25(2):185-9.
2008: Andrew D Blann; B R Nation
Good analytical practice: statistics and handling data in biomedical science. A primer and directions for authors. Part 1: Introduction. Data within and between one or two sets of individuals.
British journal of biomedical science 2008;65(4):209-17.
2007: Graham J Caine; Gregory Lip; Ulyses Zanetto; Mahwandra Maheshwari; Paul S Stonelake; Andrew D Blann
A comparison of plasma versus histologic indices of angiogenic markers in breast cancer.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2007;15(4):382-8.
2007: Christopher J Boos; Balu Balakrishnan; Shahirose Jessani; Andrew D Blann; Gregory Y H Lip
Effects of percutaneous coronary intervention on peripheral venous blood circulating endothelial cells and plasma indices of endothelial damage/dysfunction.
Chest 2007;132(6):1920-6.
2007: Rumi J Jaumdally; Chetan Varma; Andrew D Blann; Robert J MacFadyen; Gregory Y H Lip
Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplasty.
Chest 2007;132(5):1532-9.
2007: Bethan Freestone; Aun Yeong Chong; Sarah Nuttall; Andrew D Blann; Gregory Y H Lip
Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation.
Chest 2007;132(4):1253-8.
2007: Andrew D Blann
Platelets: the universal killer?
Biochimica et biophysica acta 2007;1772(7):715-7.
2007: Graham J Caine; Peter Ryan; Gregory Y H Lip; Andrew D Blann
Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients.
Cancer letters 2007;251(2):296-301.
2007: Charles G C Spencer; Dirk C Felmeden; Andrew D Blann; Gregory Y H Lip
Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
American journal of hypertension 2007;20(6):699-704.
2007: Anirban Choudhury; Irene Chung; Andrew D Blann; Gregory Y H Lip
Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
Journal of the American College of Cardiology 2007;49(19):1957-64.
2007: Graham J Caine; Paul S Stonelake; Gregory Y H Lip; Andrew D Blann
Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer.
Cancer letters 2007;248(1):131-6.
2007: George I Varughese; Jeetesh Patel; Joseph Tomson; Andrew D Blann; Elizabeth A Hughes; G Y H Lip
Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
Journal of internal medicine 2007;261(4):384-91.
2007: Anirban Choudhury; Irene Chung; Andrew D Blann; Gregory Y H Lip
Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy.
Chest 2007;131(3):809-15.
2007: Françoise Dignat-George; Florence Sabatier; Andrew D Blann; Alexander Woywodt
Detection of circulating endothelial cells: CD146-based magnetic separation enrichment or flow cytometric assay?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(5):e1-2; author reply e3-5.
2007: Christopher J Boos; Andrew D Blann; Gregory Y H Lip
Assessment of endothelial damage/dysfunction: a focus on circulating endothelial cells.
Methods in molecular medicine 2007;139():211-24.
2007: Rumi J Jaumdally; Chetan Varma; Andrew D Blann; Robert J MacFadyen; Gregory Y H Lip
Indices of angiogenesis, platelet activation, and endothelial damage/dysfunction in relation to ethnicity and coronary artery disease: differences in central versus peripheral levels.
Annals of medicine 2007;39(8):628-33.
2007: Andrew D Blann
Diagnosis, treatment and management of venous thromboembolism: recent developments relevant to biomedical scientists.
British journal of biomedical science 2007;64(3):136-41.
2007: Andrew D Blann; Sukhjinder Marwah; A J Cobley; David Bareford
Increased levels of soluble P-selectin correlate with iron overload in sickle cell disease.
British journal of biomedical science 2007;64(3):124-6.
2007: Rumi J Jaumdally; Chetan Varma; Andrew D Blann; Robert J MacFadyen; Gregory Y H Lip
Systemic and intracardiac vascular endothelial growth factor and angiopoietin-1 and -2 levels in coronary artery disease: effects of angioplasty.
Annals of medicine 2007;39(4):298-305.
2007: Anirban Choudhury; Irene Chung; Andrew D Blann; Gregory Y H Lip
Platelet adhesion in atrial fibrillation.
Thrombosis research 2007;120(4):623-9.
2007: Charles G C Spencer; Dirk C Felmeden; Andrew D Blann; G Y H Lip
Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Journal of internal medicine 2007;261(1):82-90.
2007: Claudio Ceconi; Kim M Fox; William J Remme; Marteen L Simoons; Michael Bertrand; Giovanni Parrinello; Cornelis Kluft; Andrew D Blann; Dennis V Cokkinos; Roberto Ferrari
ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT.
Cardiovascular research 2007;73(1):237-46.
2006: K W Lee; Andrew D Blann; Kate Jolly; G Y H Lip
Plasma haemostatic markers, endothelial function and ambulatory blood pressure changes with home versus hospital cardiac rehabilitation: the Birmingham Rehabilitation Uptake Maximisation Study.
Heart (British Cardiac Society) 2006;92(12):1732-8.
2006: Christopher J Boos; Gregory Y H Lip; Andrew D Blann
Circulating endothelial cells in cardiovascular disease.
Journal of the American College of Cardiology 2006;48(8):1538-47.
2006: Christopher J Boos; Deirdre Lane; Delene Kang; Patrick K Y Goon; Andrew D Blann; Gregory Y H Lip
Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood.
Journal of thrombosis and thrombolysis 2006;22(2):125-31.
2006: Sunil Nadar; Andrew D Blann; Gregory Y H Lip
Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
American journal of hypertension 2006;19(9):970-7; discussion 978.
2006: Andrew D Blann; Adolf Pretorius
Circulating endothelial cells and endothelial progenitor cells: two sides of the same coin, or two different coins?
Atherosclerosis 2006;188(1):12-8.
2006: Kaeng W Lee; Andrew D Blann; Gregory Y H Lip
Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
International journal of cardiology 2006;111(2):302-8.
2006: Patrick K Y Goon; Christopher J Boos; Paul S Stonelake; Andrew D Blann; Gregory Y H Lip
Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison.
Thrombosis and haemostasis 2006;96(1):45-52.
2006: Aun Yeong Chong; Bethan Freestone; Jeetesh Patel; Hoong Sern Lim; Elizabeth Hughes; Andrew D Blann; Gregory Y H Lip
Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
The American journal of cardiology 2006;97(5):671-5.
2006: Aun Yeong Chong; Gregory Y H Lip; Bethan Freestone; Andrew D Blann
Increased circulating endothelial cells in acute heart failure: comparison with von Willebrand factor and soluble E-selectin.
European journal of heart failure 2006;8(2):167-72.
2006: Patrick K Y Goon; G Y H Lip; C J Boos; Paul S Stonelake; Andrew D Blann
Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer.
Neoplasia (New York, N.Y.) 2006;8(2):79-88.
2006: Andrew D Blann; Graham Cain; David Bareford
Vascular endothelial growth factor and platelets in primary (essential) thrombocythaemia.
British journal of haematology 2006;132(4):530-1.
2006: Simon L Bacon; Christopher Ring; Foo Li Saw Hee; Gregory Y H Lip; Andrew D Blann; Kim L Lavoie; Douglas Carroll
Hemodynamic, hemostatic, and endothelial reactions to psychological and physical stress in coronary artery disease patients.
Biological psychology 2006;71(2):162-70.
2006: Andrew D Blann; Gregory Y H Lip
Venous thromboembolism.
BMJ (Clinical research ed.) 2006;332(7535):215-9.
2006: Andrew D Blann
Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years.
Thrombosis and haemostasis 2006;95(1):49-55.
2006: Bethan Freestone; Aun Yeong Chong; Andrew D Blann; Gregory Y H Lip
The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction.
Thrombosis research 2006;118(4):479-85.
2006: Kaeng W Lee; Andrew D Blann; Gregory Y H Lip
Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction.
Thrombosis research 2006;118(3):305-12.
2006: Junette S Mohan; G Y H Lip; David Bareford; Andrew D Blann
Platelet P-selectin and platelet mass, volume and component in sickle cell disease: relationship to genotype.
Thrombosis research 2006;117(6):623-9.
2005: Ali Hamaad; Michael D Sosin; Andrew D Blann; Jeetesh Patel; Gregory Y H Lip; Robert J MacFadyen
Markers of inflammation in acute coronary syndromes: association with increased heart rate and reductions in heart rate variability.
Clinical cardiology 2005;28(12):570-6.
2005: Kaeng W Lee; Andrew D Blann; Gregory Y H Lip
Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes.
Thrombosis and haemostasis 2005;94(5):1077-83.
2005: Sunil Nadar; Ioannis Karalis; Eman Al Yemeni; Andrew D Blann; Gregory Y H Lip
Plasma markers of angiogenesis in pregnancy induced hypertension.
Thrombosis and haemostasis 2005;94(5):1071-6.
2005: K W Lee; Andrew D Blann; J Ingram; Kate Jolly; G Y H Lip
Incremental shuttle walking is associated with activation of haemostatic and haemorheological markers in patients with coronary artery disease: the Birmingham rehabilitation uptake maximization study (BRUM).
Heart (British Cardiac Society) 2005;91(11):1413-7.
2005: Bernd Jilma; Tuende Cvitko; Astrid Winter-Fabry; Karin Petroczi; Peter Quehenberger; Andrew D Blann
High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men.
Thrombosis and haemostasis 2005;94(4):797-801.
2005: Sunil Nadar; Gregory Y H Lip; Kaeng W Lee; Andrew D Blann
Circulating endothelial cells in acute ischaemic stroke.
Thrombosis and haemostasis 2005;94(4):707-12.
2005: Bethan Freestone; Gregory Y H Lip; Aun Yeong Chong; Sunil Nadar; Kaeng W Lee; Andrew D Blann
Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease.
Thrombosis and haemostasis 2005;94(4):702-6.
2005: Kaeng W Lee; Andrew D Blann; Gregory Y H Lip
Impaired tissue Doppler diastolic function in patients with coronary artery disease: relationship to endothelial damage/dysfunction and platelet activation.
American heart journal 2005;150(4):756-66.
2005: Sunil Nadar; Andrew D Blann; D Gareth Beevers; G Y H Lip
Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Journal of internal medicine 2005;258(4):336-43.
2005: Kiat T Tan; Muzahir H Tayebjee; Robert J MacFadyen; Gregory Y H Lip; Andrew D Blann
Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation.
Platelets 2005;16(6):368-71.
2005: Junette S Mohan; Peck Lin Lip; Andrew D Blann; David Bareford; G Y H Lip
The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.
The British journal of ophthalmology 2005;89(7):815-9.
2005: H S Lim; G Y H Lip; D G Beevers; Andrew D Blann
Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
European journal of clinical investigation 2005;35(5):324-9.
2005: Hoong Sern Lim; Gregory Y H Lip; Andrew D Blann
Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis.
Atherosclerosis 2005;180(1):113-8.
2005: G Y H Lip; W Foster; Andrew D Blann
Plasma von Willebrand factor levels and surrogates of atherosclerosis.
Journal of thrombosis and haemostasis : JTH 2005;3(4):659-61.
2005: Junette S Mohan; Gregory Yh Lip; Josh Wright; David Bareford; Andrew D Blann
Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2005;16(3):209-14.
2005: Graham J Caine; Adrian L Harris; K Christodoulos; G Y H Lip; Andrew D Blann
Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer.
Cancer letters 2005;219(2):163-7.
2005: Andrew D Blann; Kiat T Tan; Muzahir H Tayebjee; Indran Davagnanam; Mark Moss; Gregory Y H Lip
Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty.
Thrombosis and haemostasis 2005;93(3):578-83.
2005: Hoong Sern Lim; Aun Yeong Chong; Bethan Freestone; Andrew D Blann; G Y H Lip
The effect of multi-factorial intervention on plasma von Willebrand factor, soluble E-selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular disease.
Diabetic medicine : a journal of the British Diabetic Association 2005;22(3):249-55.
2005: Andrew D Blann; Alexander Woywodt; Francesco Bertolini; Todd M Bull; Jill P Buyon; Robert M Clancy; Marion Haubitz; Robert P Hebbel; Gregory Y H Lip; Patrizia Mancuso; Jose Sampol; Anna Solovey; Françoise Dignat-George
Circulating endothelial cells. Biomarker of vascular disease.
Thrombosis and haemostasis 2005;93(2):228-35.
2005: Kaeng W Lee; Gregory Y H Lip; Muzahir H Tayebjee; William Foster; Andrew D Blann
Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes.
Blood 2005;105(2):526-32.
2005: Bethan Freestone; Aun Yeong Chong; Hoong Sern Lim; Andrew D Blann; Gregory Y H Lip
Angiogenic factors in atrial fibrillation: a possible role in thrombogenesis?
Annals of medicine 2005;37(5):365-72.
2005: Ioannis Karalis; Sunil Nadar; Eman Al Yemeni; Andrew D Blann; Gregory Y H Lip
Platelet activation in pregnancy-induced hypertension.
Thrombosis research 2005;116(5):377-83.
2005: Aun Yeong Chong; Bernard S P Chin; Andrew D Blann; Gregory Y H Lip
Effects of antiplatelet therapy and oral anticoagulation on indices of endothelial damage/dysfunction in patients with systolic heart failure in sinus rhythm.
Thrombosis research 2005;116(2):181-3.
2005: Kiat T Tan; Muzahir H Tayebjee; Cheryl Lynd; Andrew D Blann; Gregory Y H Lip
Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers.
Annals of medicine 2005;37(1):61-6.
2005: Sunil Nadar; Graham J Caine; Andrew D Blann; Gregory Y H Lip
Platelet adhesion in hypertension: application of a novel assay of platelet adhesion.
Annals of medicine 2005;37(1):55-60.
2005: Kaeng W Lee; Andrew D Blann; Gregory Y H Lip
High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
American journal of hypertension 2005;18(1):104-15.
2005: Muzahir H Tayebjee; Gregory Y H Lip; Andrew D Blann; Robert J MacFadyen
Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2.
Thrombosis research 2005;115(3):205-10.
2004: Sunil Nadar; Gregory Y H Lip; Andrew D Blann
Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke. The West Birmingham Stroke Project.
Thrombosis and haemostasis 2004;92(6):1342-8.
2004: Hoong Sern Lim; Andrew D Blann; Aun Yeong Chong; Bethan Freestone; Gregory Y H Lip
Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention.
Diabetes care 2004;27(12):2918-24.
2004: PL Lip; S Chatterjee; Graham J Caine; MW Hope-Ross; J Gibson; Andrew D Blann; G Y H Lip
Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
The British journal of ophthalmology 2004;88(12):1543-6.
2004: Andrew D Blann; Graham Caine; David Bareford
Abnormal vascular, platelet and coagulation markers in primary thrombocythaemia are not reversed by treatments that reduce the platelet count.
Platelets 2004;15(7):447-9.
2004: Hoong Sern Lim; Gregory Y H Lip; Andrew D Blann
Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertension.
The Journal of clinical endocrinology and metabolism 2004;89(11):5377-81.
2004: Gael Deplanque; Srinivasan Madhusudan; P H Jones; S Wellmann; K Christodoulos; Denis C Talbot; Trivadi Ganesan; Andrew D Blann; Adrian L Harris
Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma.
British journal of cancer 2004;91(9):1645-50.
2004: Kaeng W Lee; Gregory Y H Lip; Andrew D Blann
Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
Circulation 2004;110(16):2355-60.
2004: Sunil Nadar; Andrew D Blann; G Y H Lip
Plasma and platelet-derived vascular endothelial growth factor and angiopoietin-1 in hypertension: effects of antihypertensive therapy.
Journal of internal medicine 2004;256(4):331-7.
2004: Aun Yeong Chong; Andrew D Blann; Jeetesh Patel; Bethan Freestone; Elizabeth Hughes; Gregory Y H Lip
Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide.
Circulation 2004;110(13):1794-8.
2004: Muzahir H Tayebjee; Sunil Nadar; Andrew D Blann; D Gareth Beevers; Robert J MacFadyen; Gregory Y H Lip
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
American journal of hypertension 2004;17(9):764-9.
2004: Graham J Caine; Sunil Nadar; Gregory Y H Lip; Paul S Stonelake; Andrew D Blann
Platelet adhesion in breast cancer: development and application of a novel assay.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(6):513-8.
2004: D Gareth Beevers; Gregory Y H Lip; Andrew D Blann
Salt intake and Helicobacter pylori infection.
Journal of hypertension 2004;22(8):1475-7.
2004: Andrew D Blann
Angiogenesis and platelets: the clot thickens further.
Cardiovascular research 2004;63(2):192-3.
2004: Sunil Nadar; Andrew D Blann; Sridhar Kamath; D Gareth Beevers; Gregory Y H Lip
Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Journal of the American College of Cardiology 2004;44(2):415-22.
2004: P H Jones; K Christodoulos; Nicola A Dobbs; Parames Thavasu; Frances R Balkwill; Andrew D Blann; Graham J Caine; S Kumar; A J Kakkar; N Gompertz; Denis C Talbot; Trivadi Ganesan; Adrian L Harris
Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer.
British journal of cancer 2004;91(1):30-6.
2004: Graham J Caine; Gregory Y H Lip; Paul S Stonelake; Peter Ryan; Andrew D Blann
Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma.
Thrombosis and haemostasis 2004;92(1):185-90.
2004: Hoong Sern Lim; Andrew D Blann; Gregory Y H Lip
Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention.
Circulation 2004;109(21):2524-8.
2004: Charles G C Spencer; Steven C Martin; Dirk C Felmeden; Andrew D Blann; Gareth D Beevers; Gregory Y H Lip
Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
International journal of cardiology 2004;94(2-3):293-300.
2004: Vanessa Roldán; Francisco Marin; Andrew D Blann
Soluble E-selectin, interleukin-6 and tissue factor in two cases of meningococcal septicaemia.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(2):179-82.
2004: Andrew J Makin; Andrew D Blann; Natali A Y Chung; Stanley H Silverman; Gregory Y H Lip
Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.
European heart journal 2004;25(5):371-6.
2004: Funmi M Belgore; Andrew D Blann; D Neil; A S Ahmed; G Y H Lip
Localisation of members of the vascular endothelial growth factor (VEGF) family and their receptors in human atherosclerotic arteries.
Journal of clinical pathology 2004;57(3):266-72.
2004: Aun Yeong Chong; Graham J Caine; Bethan Freestone; Andrew D Blann; Gregory Y H Lip
Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.
Journal of the American College of Cardiology 2004;43(3):423-8.
2004: Martin J Landray; David C Wheeler; Gregory Y H Lip; David Newman; Andrew D Blann; Fiona J McGlynn; Simon Ball; Jonathan N Townend; Colin Baigent
Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(2):244-53.
2004: Sunil Nadar; Andrew D Blann; Gregory Y H Lip
Antihypertensive therapy and endothelial function.
Current pharmaceutical design 2004;10(29):3607-14.
2004: Sunil Nadar; Andrew D Blann; Gregory Y H Lip
Endothelial dysfunction: methods of assessment and application to hypertension.
Current pharmaceutical design 2004;10(29):3591-605.
2004: Sunil Nadar; Andrew D Blann; Gregory Y H Lip
Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy.
Annals of medicine 2004;36(7):552-7.
2004: Graham J Caine; Gregory Y Lip; Andrew D Blann
Platelet-derived VEGF, Flt-1, angiopoietin-1 and P-selectin in breast and prostate cancer: further evidence for a role of platelets in tumour angiogenesis.
Annals of medicine 2004;36(4):273-7.
2004: Gregory Y H Lip; Andrew D Blann
Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new 'vascular triad'.
Annals of medicine 2004;36(2):119-25.
2004: Sunil Nadar; Eman Al Yemeni; Andrew D Blann; Gregory Y H Lip
Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.
Thrombosis research 2004;113(2):123-8.
2004: Charles G C Spencer; David Gurney; Dirk C Felmeden; Andrew D Blann; D Gareth Beevers; G Y H Lip
Platelet and haemorheological markers in 'high risk' hypertensives are improved by tighter blood pressure control and cardiovascular risk management: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Journal of internal medicine 2004;255(1):59-67.
2003: Andrew D Blann; Sunil Nadar; Gregory Y H Lip
The adhesion molecule P-selectin and cardiovascular disease.
European heart journal 2003;24(24):2166-79.
2003: Vanessa Roldán; Francisco Marín; Gregory Y H Lip; Andrew D Blann
Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature.
Thrombosis and haemostasis 2003;90(6):1007-20.
2003: Natali A Y Chung; C Lydakis; Funmi M Belgore; Foo Leong Li-Saw-Hee; Andrew D Blann; G Y H Lip
Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease.
Heart (British Cardiac Society) 2003;89(12):1411-5.
2003: Bernard S P Chin; Andrew D Blann; Christopher R Gibbs; Natali A Y Chung; D G Conway; G Y H Lip
Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure.
European journal of clinical investigation 2003;33(11):941-8.
2003: Graham J Caine; Andrew D Blann; Paul S Stonelake; Peter Ryan; G Y H Lip
Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1.
European journal of clinical investigation 2003;33(10):883-90.
2003: Funmi M Belgore; G Y H Lip; Andrew D Blann
Basic fibrobrast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells.
European journal of clinical investigation 2003;33(10):833-9.
2003: Bernard S P Chin; Christopher R Gibbs; Andrew D Blann; Gregory Y H Lip
Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
Clinical science (London, England : 1979) 2003;105(4):507-12.
2003: Françoise Dignat-George; José Sampol; Gregory Lip; Andrew D Blann
Circulating endothelial cells: realities and promises in vascular disorders.
Pathophysiology of haemostasis and thrombosis 2003;33(5-6):495-9.
2003: Andrew D Blann
How a damaged blood vessel wall contibutes to thrombosis and hypertenasion.
Pathophysiology of haemostasis and thrombosis 2003;33(5-6):445-8.
2003: Andrew D Blann
Assessment of endothelial dysfunction: focus on atherothrombotic disease.
Pathophysiology of haemostasis and thrombosis 2003;33(5-6):256-61.
2003: Joël Constans; Remy Dupuy; Andrew D Blann; Francois Resplandy; Martine Seigneur; Martine Renard; Maïté Longy-Boursier; Thierry Schaeverbeke; Viviane Guérin; Michel René Boisseau; Claude Conri
Anti-endothelial cell autoantibodies and soluble markers of endothelial cell dysfunction in systemic lupus erythematosus.
The Journal of rheumatology 2003;30(9):1963-6.
2003: Bernard S P Chin; Dwayne S G Conway; Natali A Y Chung; Andrew D Blann; Christopher R Gibbs; Gregory Y H Lip
Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(6):515-21.
2003: Dirk C Felmeden; Charles G C Spencer; Natali A Y Chung; Funmi M Belgore; Andrew D Blann; D Gareth Beevers; Gregory Y H Lip
Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]).
The American journal of cardiology 2003;92(4):400-5.
2003: Vanessa Roldán; Francisco Marin; Andrew D Blann; Amaya García; Pascual Marco; Francisco Sogorb; Gregory Y H Lip
Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation.
European heart journal 2003;24(14):1373-80.
2003: Rob Fijnheer; Andrew D Blann
The endothelium and coagulopathy in systemic lupus erythematosus: hyperhomocysteinemia as a developing risk factor.
The Journal of rheumatology 2003;30(7):1400-2.
2003: Sunil Nadar; Andrew D Blann; Gregory Y H Lip
Homocysteine is unlikely to be associated with the risk of thromboembolic complications in atrial fibrillation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(5):513-4.
2003: Dirk C Felmeden; Andrew D Blann; Charles G C Spencer; D Gareth Beevers; G Y H Lip
A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(5):425-31.
2003: Kiat T Tan; Gregory Y H Lip; Andrew D Blann
Post-stroke inflammatory response: effects of stroke evolution and outcome.
Current atherosclerosis reports 2003;5(4):245-51.
2003: Andrew D Blann; Sunil Nadar; Gregory Y H Lip
Pharmacological modulation of platelet function in hypertension.
Hypertension 2003;42(1):1-7.
2003: Kiat T Tan; Andrew D Blann
To stroke or not to stroke: is ICAM-1 or CRP the answer?
Neurology 2003;60(12):1884-5.
2003: Andrew D Blann; Gregory Y H Lip
Effects of C-reactive protein on the release of von Willebrand factor, E-selectin, thrombomodulin and intercellular adhesion molecule-1 from human umbilical vein endothelial cells.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(4):335-40.
2003: Monika Graninger; Claudia Marsik; Tanja Dukic; Oswald F Wagner; Andrew D Blann; Bernd Jilma
Enalapril does not alter adhesion molecule levels in human endotoxemia.
Shock (Augusta, Ga.) 2003;19(5):448-51.
2003: Graham J Caine; Andrew D Blann
Soluble p-selectin should be measured in citrated plasma, not in serum.
British journal of haematology 2003;121(3):530-2.
2003: Andrew D Blann; Sukhjinder Marwah; Graham R Serjeant; David Bareford; Josh Wright
Platelet activation and endothelial cell dysfunction in sickle cell disease is unrelated to reduced antioxidant capacity.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(3):255-9.
2003: Dirk C Felmeden; Andrew D Blann; G Y H Lip
Angiogenesis: basic pathophysiology and implications for disease.
European heart journal 2003;24(7):586-603.
2003: Aun Yeong Chong; Andrew D Blann; G Y H Lip
Assessment of endothelial damage and dysfunction: observations in relation to heart failure.
QJM : monthly journal of the Association of Physicians 2003;96(4):253-67.
2003: Bernard S P Chin; Nigel J Langford; Sarah L Nuttall; Christopher R Gibbs; Andrew D Blann; Gregory Y H Lip
Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure.
European journal of heart failure 2003;5(2):171-4.
2003: Dirk C Felmeden; Charles G C Spencer; Andrew D Blann; D Gareth Beevers; Gregory Y H Lip
Low-density lipoprotein subfractions and cardiovascular risk in hypertension: relationship to endothelial dysfunction and effects of treatment.
Hypertension 2003;41(3):528-33.
2003: Andrew D Blann; Joël Constans; P Carpentier; Martine Renard; B Satger; Viviane Guérin; Michel René Boisseau; N Neau-Cransac; Claude Conri
Soluble P selectin in systemic sclerosis: relationship with von Willebrand factor, autoantibodies and diffuse or localised/limited disease.
Thrombosis research 2003;109(4):203-6.
2003: Andrew D Blann; David A Fitzmaurice; Gregory Y H Lip
Anticoagulation in hospitals and general practice.
BMJ (Clinical research ed.) 2003;326(7381):153-6.
2003: Graham J Caine; Andrew D Blann; Paul S Stonelake; Sean T Kehoe; Gregory Y H Lip
Tamoxifen for breast-cancer prevention.
Lancet 2003;361(9352):177-8; author reply 178.
2003: Andrew D Blann; G Burrows; C N McCollum
Oxidised and native low-density lipoproteins induce the release of von Willebrand factor from human endothelial cells in vitro.
British journal of biomedical science 2003;60(3):155-60.
2003: Dirk C Felmeden; Charles G C Spencer; Andrew D Blann; D Gareth Beevers; G Y H Lip
Physical activity in relation to indices of endothelial function and angiogenesis factors in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Journal of internal medicine 2003;253(1):81-91.
2003: Dirk C Felmeden; Charles G C Spencer; Funmi M Belgore; Andrew D Blann; D Gareth Beevers; Gregory Y H Lip
Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management.
American journal of hypertension 2003;16(1):11-20.
2002: Bernard S P Chin; Natali A Y Chung; Christopher R Gibbs; Andrew D Blann; Gregory Y H Lip
Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure.
The American journal of cardiology 2002;90(11):1258-60.
2002: Sridhar Kamath; Andrew D Blann; Bernard S P Chin; F Lanza; B Aleil; J P Cazenave; G Y H Lip
A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy.
European heart journal 2002;23(22):1788-95.
2002: Peck Lin Lip; Dirk C Felmeden; Andrew D Blann; N Matheou; S Thakur; I A Cunliffe; G Y H Lip
Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma.
The British journal of ophthalmology 2002;86(11):1299-302.
2002: David A Fitzmaurice; Andrew D Blann; Gregory Y H Lip
Bleeding risks of antithrombotic therapy.
BMJ (Clinical research ed.) 2002;325(7368):828-31.
2002: Andrew D Blann; Martin J Landray; Gregory Y H Lip
ABC of antithrombotic therapy: An overview of antithrombotic therapy.
BMJ (Clinical research ed.) 2002;325(7367):762-5.
2002: Andrew D Blann; NR Williams; G Y H Lip; J Rajput-Williams; AN Howard
Acute ingestion of red wine by men activates platelets but does not influence endothelial markers: no effect of white wine.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(7):647-51.
2002: Natali A Y Chung; C Lydakis; Funmi M Belgore; Andrew D Blann; G Y H Lip
Angiogenesis in myocardial infarction. An acute or chronic process?
European heart journal 2002;23(20):1604-8.
2002: Natali A Y Chung; Funmi M Belgore; Foo Leong Li-Saw-Hee; Dwayne S G Conway; Andrew D Blann; Gregory Y H Lip
Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor?
Stroke; a journal of cerebral circulation 2002;33(9):2187-91.
2002: Andrew D Blann; Paul M Ridker; Gregory Y H Lip
Inflammation, cell adhesion molecules, and stroke: tools in pathophysiology and epidemiology?
Stroke; a journal of cerebral circulation 2002;33(9):2141-3.
2002: Andrew D Blann; Charles N McCollum; Gregory Y H Lip
Relationship between plasma markers of endothelial cell integrity and the Framingham cardiovascular disease risk-factor scores in apparently healthy individuals.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(6):513-8.
2002: Sridhar Kamath; Andrew D Blann; Bernard S P Chin; Gregory Y H Lip
A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.
Journal of the American College of Cardiology 2002;40(3):484-90.
2002: Charles G C Spencer; David Gurney; Andrew D Blann; D Gareth Beevers; Gregory Y H Lip
Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Hypertension 2002;40(1):61-6.
2002: David Gurney; Gregory Y H Lip; Andrew D Blann
A reliable plasma marker of platelet activation: does it exist?
American journal of hematology 2002;70(2):139-44.
2002: G Y H Lip; Andrew D Blann; I S Farooqi; J Zarifis; G Sagar; D Gareth Beevers
Sequential alterations in haemorheology, endothelial dysfunction, platelet activation and thrombogenesis in relation to prognosis following acute stroke: The West Birmingham Stroke Project.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(4):339-47.
2002: G Y H Lip; E Edmunds; S L Nuttall; Martin J Landray; Andrew D Blann; D Gareth Beevers
Oxidative stress in malignant and non-malignant phase hypertension.
Journal of human hypertension 2002;16(5):333-6.
2002: Sridhar Kamath; Andrew D Blann; Graham J Caine; David Gurney; Bernard S P Chin; Gregory Y H Lip
Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillation.
Stroke; a journal of cerebral circulation 2002;33(5):1237-42.
2002: Sukhjinder Marwah; Andrew D Blann; P Harrison; M A Lumley; J Wright; J McDowell; JD Phillips; C Rea; David Bareford
Increased non-transferrin bound iron in plasma-depleted SAG-M red blood cell units.
Vox sanguinis 2002;82(3):122-6.
2002: Andrew D Blann; Gregory Y H Lip
Soluble adhesion molecules and coronary heart disease.
Lancet 2002;359(9305):525-6; author reply 526-7.
2002: Sukhjinder Marwah; Andrew D Blann; C Rea; JD Phillips; J Wright; David Bareford
Reduced vitamin E antioxidant capacity in sickle cell disease is related to transfusion status but not to sickle crisis.
American journal of hematology 2002;69(2):144-6.
2002: Andrew D Blann; I C Nitu-Whalley; C A Lee; G Y H Lip
Inverse relationship between plasma von Willebrand factor and soluble P selectin in patients with type 1 but not type 2 von Willebrand disease.
American journal of hematology 2002;69(2):135-7.
2002: Andrew D Blann; Funmi M Belgore; Charles N McCollum; Stanley Silverman; Peck Lin Lip; Gregory Y H Lip
Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes.
Clinical science (London, England : 1979) 2002;102(2):187-94.
2002: G Y H Lip; Andrew D Blann; E Edmunds; D Gareth Beevers
Baseline abnormalities of endothelial function and thrombogenesis in relation to prognosis in essential hypertension.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(1):35-41.
2002: Gregory Y H Lip; Bernard S P Chin; Andrew D Blann
Cancer and the prothrombotic state.
The lancet oncology 2002;3(1):27-34.
2001: Sridhar Kamath; Andrew D Blann; Gregory Y H Lip
Platelets and atrial fibrillation.
European heart journal 2001;22(24):2233-42.
2001: CR Gibbs; Andrew D Blann; E Edmunds; RD Watson; Gregory Y H Lip
Effects of acute exercise on hemorheological, endothelial, and platelet markers in patients with chronic heart failure in sinus rhythm.
Clinical cardiology 2001;24(11):724-9.
2001: Andrew D Blann; F Lanza; P Galajda; D Gurney; S Moog; J P Cazenave; Gregory Y H Lip
Increased platelet glycoprotein V levels in patients with coronary and peripheral atherosclerosis--the influence of aspirin and cigarette smoking.
Thrombosis and haemostasis 2001;86(3):777-83.
2001: Sukhjinder Marwah; D Wheelwright; Andrew D Blann; C Rea; R Beresford; JD Phillips; J Wright; David Bareford
Vitamin E correlates inversely with non-transferrin-bound iron in sickle cell disease.
British journal of haematology 2001;114(4):917-9.
2001: Andrew D Blann; R Adams; Raymond J Ashleigh; S Naser; Ursula Kirkpatrick; Charles N McCollum
Changes in endothelial, leucocyte and platelet markers following contrast medium injection during angiography in patients with peripheral artery disease.
The British journal of radiology 2001;74(885):811-7.
2001: Foo Leong Li-Saw-Hee; Andrew D Blann; D Gurney; Gregory Y H Lip
Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
European heart journal 2001;22(18):1741-7.
2001: Sridhar Kamath; Andrew D Blann; Gregory Y H Lip
Platelet activation: assessment and quantification.
European heart journal 2001;22(17):1561-71.
2001: Gregory Y H Lip; E Edmunds; F L Hee; Andrew D Blann; D Gareth Beevers
A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension.
American journal of hypertension 2001;14(8 Pt 1):823-8.
2001: Gregory Y H Lip; E Edmunds; SC Martin; Alan F Jones; Andrew D Blann; D Gareth Beevers
A pilot study of homocyst(e)ine levels in essential hypertension: relationship to von Willebrand factor, an index of endothelial damage.
American journal of hypertension 2001;14(7 Pt 1):627-31.
2001: Andrew D Blann; David Gurney; Elizabeth Hughes; P Buggins; S H Silverman; Gregory Y H Lip
Influence of pravastatin on lipoproteins, and on endothelial, platelet, and inflammatory markers in subjects with peripheral artery disease.
The American journal of cardiology 2001;88(1):A7-8, 89-92.
2001: Gregory Y H Lip; Andrew D Blann; I S Farooqi; J Zarifis; G Sagar; D Gareth Beevers
Abnormal haemorheology, endothelial function and thrombogenesis in relation to hypertension in acute (ictus < 12 h) stroke patients: the West Birmingham Stroke Project.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(4):307-15.
2001: Andrew D Blann; Funmi M Belgore; Joël Constans; Claude Conri; Gregory Y H Lip
Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate.
The American journal of cardiology 2001;87(10):1160-3.
2001: Foo Leong Li-Saw-Hee; Andrew D Blann; E Edmunds; CR Gibbs; Gregory Y H Lip
Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation.
Clinical cardiology 2001;24(5):409-14.
2001: Funmi M Belgore; Andrew D Blann; Gregory Y H Lip
Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays.
Clinical science (London, England : 1979) 2001;100(5):567-75.
2001: CR Gibbs; Andrew D Blann; RD Watson; Gregory Y H Lip
Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy.
Circulation 2001;103(13):1746-51.
2001: PL Lip; Andrew D Blann; MW Hope-Ross; JM Gibson; Gregory Y H Lip
Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction.
Ophthalmology 2001;108(4):705-10.
2001: Funmi M Belgore; Andrew D Blann; Foo Leong Li-Saw-Hee; D Gareth Beevers; Gregory Y H Lip
Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension.
The American journal of cardiology 2001;87(6):805-7, A9.
2001: Funmi M Belgore; Gregory Y H Lip; David Bareford; M Wadley; Paul S Stonelake; Andrew D Blann
Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, Flt-1, in haematological cancers: a comparison with breast cancer.
American journal of hematology 2001;66(1):59-61.
2001: Andrew D Blann; J Amiral; D A Taberner
Platelet and endothelial-cell markers in meningococcal septicaemia: a report of two cases.
British journal of biomedical science 2001;58(1):37-40.
2001: Andrew D Blann; D Gurney; M Wadley; David Bareford; Paul S Stonelake; Gregory Y H Lip
Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(1):43-50.
2001: Ira R A Goldsmith; Andrew D Blann; Ramesh L Patel; Gregory Y H Lip
Effect of aortic valve replacement on plasma soluble P-selectin, von Willebrand factor, and fibrinogen.
The American journal of cardiology 2001;87(1):107-10, A9.
2000: Jeremy P Braybrooke; KJ O'Byrne; David J Propper; Andrew D Blann; M Saunders; Nicola A Dobbs; C Han; J Woodhull; K Mitchell; Jeremy P Crew; K Smith; R Stephens; Trivadi Ganesan; Denis C Talbot; Adrian L Harris
A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(12):4697-704.
2000: Ira R A Goldsmith; P Kumar; P Carter; Andrew D Blann; Ramesh L Patel; Gregory Y H Lip
Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study.
American heart journal 2000;140(5):777-84.
2000: Gregory Y H Lip; C Lydakis; S L Nuttall; Martin J Landray; Robert D Watson; Andrew D Blann
A pilot study of streptokinase-induced endothelial injury and platelet activation following acute myocardial infarction.
Journal of internal medicine 2000;248(4):316-8.
2000: Andrew D Blann
Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms?
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2000;11(7):623-30.
2000: Foo Leong Li-Saw-Hee; Andrew D Blann; Gregory Y H Lip
Effect of degree of blood pressure on the hypercoagulable state in chronic atrial fibrillation.
The American journal of cardiology 2000;86(7):795-7, A9.
2000: Joël Constans; Martine Seigneur; Andrew D Blann; B Lestage; Francois Resplandy; Martine Renard; B Chaudet; J Amiral; Viviane Guérin; Michel René Boisseau; Claude Conri
Endothelial function, platelet activation and coagulation in lower limb occlusive arterial disease during treadmill exercise: correlations with transcutaneous oxygen pressure.
Thrombosis research 2000;99(6):557-61.
2000: Andrew D Blann; J Amiral; Charles N McCollum; Gregory Y H Lip
Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls.
Atherosclerosis 2000;152(1):29-34.
2000: Foo Leong Li-Saw-Hee; E Edmunds; Andrew D Blann; D Gareth Beevers; Gregory Y H Lip
Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy.
International journal of cardiology 2000;75(1):43-7.
2000: Funmi M Belgore; G Y Lip; David Bareford; Andrew D Blann
Plasma levels of vascular endothelial growth factor (VEGF) in haematological cancers.
British journal of haematology 2000;110(2):496-7.
2000: Ira R A Goldsmith; L S Foo; Andrew D Blann; Gregory Y H Lip
Increased platelet activation and endothelial dysfunction in patients with atrial fibrillation immediately following percutaneous balloon mitral valvuloplasty.
Clinical cardiology 2000;23(8):587-90.
2000: Ira R A Goldsmith; Andrew D Blann; Ramesh L Patel; Gregory Y H Lip
Reduced indexes of left atrial hypercoagulability in patients with severe mitral regurgitation.
The American journal of cardiology 2000;86(2):234-6.
2000: PL Lip; Funmi M Belgore; Andrew D Blann; MW Hope-Ross; JM Gibson; Gregory Y H Lip
Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
Investigative ophthalmology & visual science 2000;41(8):2115-9.
2000: Foo Leong Li-Saw-Hee; Andrew D Blann; Gregory Y H Lip
A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation.
Journal of the American College of Cardiology 2000;35(7):1926-31.
2000: Ira R A Goldsmith; Andrew D Blann; Ramesh L Patel; Gregory Y H Lip
von Willebrand factor, fibrinogen, and soluble P-selectin levels after mitral valve replacement versus mitral valve repair.
The American journal of cardiology 2000;85(10):1218-22.
2000: Ira R A Goldsmith; Andrew D Blann; Ramesh L Patel; G Y Lip
Plasma fibrinogen, soluble P-selectin, and von Willebrand factor in aortic valve disease: evidence for abnormal haemorheology, platelet activation, and endothelial dysfunction.
Heart (British Cardiac Society) 2000;83(5):577-8.
2000: Foo Leong Li-Saw-Hee; Andrew D Blann; Gregory Y H Lip
Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.
Stroke; a journal of cerebral circulation 2000;31(4):828-33.
2000: Andrew D Blann; A Farrell; AJ Picton; Charles N McCollum
Relationship between endothelial cell markers and arterial stenosis in peripheral and carotid artery disease.
Thrombosis research 2000;97(4):209-16.
2000: Joël Constans; Andrew D Blann; Martine Renard; Viviane Guérin; Claude Conri
Soluble thrombomodulin in hypercholesterolaemic patients.
Lancet 2000;355(9198):145.
2000: Ursula Kirkpatrick; Andrew D Blann; R A Adams; Charles N McCollum
Soluble adhesion molecules in clinical ischaemic injury.
International journal of surgical investigation 2000;2(2):151-8.
2000: Funmi M Belgore; Gregory Y H Lip; Andrew D Blann
Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers.
British journal of biomedical science 2000;57(3):207-13.
2000: Andrew D Blann; W M Noteboom; F R Rosendaal
Increased soluble P-selectin levels following deep venous thrombosis: cause or effect?
British journal of haematology 2000;108(1):191-3.
1999: Joël Constans; Andrew D Blann; Francois Resplandy; Françoise Parrot; Martine Renard; Martine Seigneur; Viviane Guérin; Michel René Boisseau; Claude Conri
Three months supplementation of hyperhomocysteinaemic patients with folic acid and vitamin B6 improves biological markers of endothelial dysfunction.
British journal of haematology 1999;107(4):776-8.
1999: Joël Constans; Andrew D Blann; Francois Resplandy; Françoise Parrot; Martine Seigneur; Martine Renard; J Amiral; Viviane Guérin; Michel René Boisseau; Claude Conri
Endothelial dysfunction during acute methionine load in hyperhomocysteinaemic patients.
Atherosclerosis 1999;147(2):411-3.
1999: Andrew D Blann; J Hewitt; F Siddiqui; David Bareford
Racial background is a determinant of average warfarin dose required to maintain the INR between 2.0 and 3.0.
British journal of haematology 1999;107(1):207-9.
1999: Gregory Y H Lip; Andrew D Blann; D Gareth Beevers
Prothrombotic factors, endothelial function and left ventricular hypertrophy in isolated systolic hypertension compared with systolic-diastolic hypertension.
Journal of hypertension 1999;17(8):1203-7.
1999: Andrew D Blann; P Kumar; J Krupinski; C McCollum; D Gareth Beevers; Gregory Y H Lip
Soluble intercelluar adhesion molecule-1, E-selectin, vascular cell adhesion molecule-1 and von Willebrand factor in stroke.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1999;10(5):277-84.
1999: Foo Leong Li-Saw-Hee; Andrew D Blann; I Goldsmith; Gregory Y H Lip
Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis.
The American journal of cardiology 1999;83(8):1206-9.
1999: Bernd Jilma; Andrew D Blann; Thomas Pernerstorfer; PJ Stohlawetz; Hans-Georg Eichler; B Vondrovec; J Amiral; Volker Richter; Oswald F Wagner
Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin.
American journal of respiratory and critical care medicine 1999;159(3):857-63.
1999: Ursula Kirkpatrick; G Burrows; Andrew D Blann; Charles N McCollum
Neutrophil activation and severity of tissue hypoxia during tourniquet-induced forearm ischemia in man.
Experimental and molecular pathology 1999;65(3):111-20.
1998: Joël Constans; Martine Seigneur; Andrew D Blann; Martine Renard; Francois Resplandy; J Amiral; Viviane Guérin; Michel René Boisseau; Claude Conri
Effect of the antioxidants selenium and beta-carotene on HIV-related endothelium dysfunction.
Thrombosis and haemostasis 1998;80(6):1015-7.
1998: Andrew D Blann; Ursula Kirkpatrick; C Devine; S Naser; Charles N McCollum
The influence of acute smoking on leucocytes, platelets and the endothelium.
Atherosclerosis 1998;141(1):133-9.
1998: Andrew D Blann; A Bignell; C McCollum
von Willebrand factor, fibrinogen and other plasma proteins as determinants of plasma viscosity.
Atherosclerosis 1998;139(2):317-22.
1998: Andrew D Blann; Gregory Y H Lip
Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 1998;15(8):634-42.
1998: Andrew D Blann
Adhesion molecules in cardiovascular disease: opportunities for new therapeutic directions?
IDrugs : the investigational drugs journal 1998;1(3):315-20.
1998: Andrew D Blann; Gregory Y H Lip
The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9(4):297-306.
1998: Andrew D Blann; Martine Seigneur; M Steiner; J P Miller; Charles N McCollum
Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events.
Thrombosis and haemostasis 1998;79(6):1080-5.
1998: Joël Constans; Viviane Guérin; A Couchouron; Martine Seigneur; A Ryman; Andrew D Blann; J Amiral; A Amara; Evelyne Peuchant; J F Moreau; Isabelle Pellegrin; J L Pellegrin; Hervé Fleury; Bingfeng Leng; Claude Conri
Autoantibodies directed against phospholipids or human beta 2-glycoprotein I in HIV-seropositive patients: relationship with endothelial activation and antimalonic dialdehyde antibodies.
European journal of clinical investigation 1998;28(2):115-22.
1998: PL Lip; Andrew D Blann; Alan F Jones; Gregory Y H Lip
Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk.
Eye (London, England) 1998;12 ( Pt 2)():245-51.
1997: Gregory Y H Lip; Andrew D Blann; Alan F Jones; PL Lip; D Gareth Beevers
Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy.
The American journal of cardiology 1997;80(12):1566-71.
1997: Andrew D Blann; Gregory Y H Lip
Platelets and hypertension: the pressure is on the clot.
Journal of human hypertension 1997;11(12):763-4.
1997: Ursula Kirkpatrick; M Mossa; Andrew D Blann; Charles N McCollum
Repeated exercise induces release of soluble P-selectin in patients with intermittent claudication.
Thrombosis and haemostasis 1997;78(5):1338-42.
1997: Andrew D Blann; Martine Seigneur; M Steiner; Michel René Boisseau; Charles N McCollum
Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease.
European journal of clinical investigation 1997;27(11):916-21.
1997: Andrew D Blann; EB Faragher; Charles N McCollum
Increased soluble P-selectin following myocardial infarction: a new marker for the progression of atherosclerosis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1997;8(7):383-90.
1997: Gregory Y H Lip; Andrew D Blann; Alan F Jones; D Gareth Beevers
Effects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis.
American heart journal 1997;134(4):764-71.
1997: F L Li-Saw-Hee; Andrew D Blann; Gregory Y H Lip
The detection of endothelial dysfunction in patients with essential hypertension.
International journal of cardiology 1997;61(2):171-4.
1997: Andrew D Blann; J P Miller; Charles N McCollum
von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia.
Atherosclerosis 1997;132(2):151-6.
1997: Andrew D Blann; Gregory Y H Lip; D G Beevers; C N McCollum
Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers.
Thrombosis and haemostasis 1997;77(6):1077-80.
1997: Gregory Y H Lip; Andrew D Blann
von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?
Cardiovascular research 1997;34(2):255-65.
1997: Martine Seigneur; Joël Constans; Andrew D Blann; Martine Renard; J L Pellegrin; J Amiral; Michel René Boisseau; Claude Conri
Soluble adhesion molecules and endothelial cell damage in HIV infected patients.
Thrombosis and haemostasis 1997;77(4):646-9.
1997: Andrew D Blann; T P Sheeran; P Emery
von Willebrand factor: increased levels are related to poor prognosis in systemic sclerosis and not to tissue autoantibodies.
British journal of biomedical science 1997;54(1):5-9.
1997: Andrew D Blann; C Steele; Charles N McCollum
The influence of smoking on soluble adhesion molecules and endothelial cell markers.
Thrombosis research 1997;85(5):433-8.
1997: Andrew D Blann; G Y Lip
Hypothesis: is soluble P-selectin a new marker of platelet activation?
Atherosclerosis 1997;128(2):135-8.
1997: Andrew D Blann; Martine Seigneur
Soluble markers of endothelial cell function.
Clinical hemorheology and microcirculation 1997;17(1):3-11.
1996: Andrew D Blann; Martine Seigneur; M R Boisseau; D A Taberner; Charles N McCollum
Soluble P selectin in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease and its risk factors.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1996;7(8):789-93.
1996: S Richard; Martine Seigneur; Andrew D Blann; R Adams; Martine Renard; M Puntous; Jean-Michel Boiron; J Amiral; Josy Reiffers; Michel René Boisseau
Vascular endothelial lesion in patients undergoing bone marrow transplantation.
Bone marrow transplantation 1996;18(5):955-9.
1996: Andrew D Blann; J Amiral; Charles N McCollum
Circulating endothelial cell/leucocyte adhesion molecules in ischaemic heart disease.
British journal of haematology 1996;95(2):263-5.
1996: Andrew D Blann; J Morris; C McCollum
Soluble L-selectin in peripheral arterial disease: relationship with soluble E-selectin and soluble P-selectin.
Atherosclerosis 1996;126(2):227-31.
1996: Andrew D Blann; P A Sanders; A Herrick; M I Jayson
Soluble L-selectin in the connective tissue diseases.
British journal of haematology 1996;95(1):192-4.
1996: R J Daly; Andrew D Blann
Self-reported smoking in vascular disease: the need for biochemical confirmation.
British journal of biomedical science 1996;53(3):204-8.
1996: Andrew D Blann; M Seigneur; R A Adams; Charles N McCollum
Neutrophil elastase, von Willebrand factor, soluble thrombomodulin and percutaneous oxygen in peripheral atherosclerosis.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 1996;12(2):218-22.
1996: Andrew D Blann; R A Adams; F Katai; R Ashleigh; D A Taberner
Haematology and coagulation indices in paired samples of arterial and venous blood from patients with arterial disease.
Haemostasis 1996;26(2):72-8.
1996: Andrew D Blann; M A Waite
von Willebrand factor and soluble E-selectin in hypertension: influence of treatment and value in predicting the progression of atherosclerosis.
Coronary artery disease 1996;7(2):143-7.
1996: Andrew D Blann; J M Wang; P B Wilson; S Kumar
Serum levels of the TGF-beta receptor are increased in atherosclerosis.
Atherosclerosis 1996;120(1-2):221-6.
1996: Andrew D Blann; R J Daly; J Amiral
The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules.
British journal of haematology 1996;92(2):498-500.
1995: Gregory Y H Lip; Andrew D Blann; J Zarifis; Michele Beevers; PL Lip; D G Beevers
Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
Journal of hypertension 1995;13(12 Pt 2):1674-8.
1995: Andrew D Blann; A Herrick; M I Jayson
Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis.
British journal of rheumatology 1995;34(9):814-9.
1995: Andrew D Blann; M Dobrotova; P Kubisz; Charles N McCollum
von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.
Thrombosis and haemostasis 1995;74(2):626-30.
1995: Andrew D Blann; S R Maxwell; G Burrows; J P Miller
Antioxidants, von Willebrand factor and endothelial cell injury in hypercholesterolaemia and vascular disease.
Atherosclerosis 1995;116(2):191-8.
1995: Andrew D Blann; D A Taberner
A reliable marker of endothelial cell dysfunction: does it exist?
British journal of haematology 1995;90(2):244-8.
1995: Andrew D Blann; H Mather; J P Miller; C N McCollum
Atherosclerosis risk factors: variation in healthy hospital workers and members of local communities asymptomatic for vascular disease. Implications for normal controls.
British journal of biomedical science 1995;52(1):31-4.
1994: Andrew D Blann; W Tse; S J Maxwell; M A Waite
Increased levels of the soluble adhesion molecule E-selectin in essential hypertension.
Journal of hypertension 1994;12(8):925-8.
1994: Andrew D Blann; Charles N McCollum
Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis.
Thrombosis and haemostasis 1994;72(1):151-4.
1993: Andrew D Blann; D Bushell; A Davies; E B Faragher; J P Miller; C N McCollum
von Willebrand factor, the endothelium and obesity.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1993;17(12):723-5.
1993: Andrew D Blann; H Midgley; G Burrows; S Maxwell; S Utting; M Davies; M Waite; C McCollum
Free radicals, antioxidants, and endothelial cell damage after percutaneous transluminal coronary angioplasty.
Coronary artery disease 1993;4(10):905-10.
1993: Andrew D Blann
von Willebrand factor and the endothelium in vascular disease.
British journal of biomedical science 1993;50(2):125-34.
1993: Andrew D Blann; T Naqvi; M Waite; C N McCollum
von Willebrand factor and endothelial damage in essential hypertension.
Journal of human hypertension 1993;7(2):107-11.
1993: Andrew D Blann; H S Midgley; G Burrows; S Maxwell; S Utting; M A Waite
Oxygen free radicals, reperfusion injury, endothelial cells, and von Willebrand factor.
Cardiovascular research 1993;27(1):141-2.
1991: Andrew D Blann
von Willebrand factor antigen as an acute phase reactant and marker of endothelial cell injury in connective tissue diseases: a comparison with CRP, rheumatoid factor, and erythrocyte sedimentation rate.
Zeitschrift für Rheumatologie 1991;50(5):320-2.